Target intelligence / Profile preview

Peripheral nerve regeneration

Molecular classification
Other
01

Overview

Peripheral nerve regeneration is the endogenous process by which peripheral nerves repair after injury, comprising axonal regrowth, myelin clearance and remodeling, Schwann cell and macrophage activation, and reinnervation of end organs[1][4][5][9]. This process is orchestrated by multiple molecular mediators, including neurotrophic factors (NGF, BDNF, GDNF, IGF-1, FGF), cytokines (such as TGF-β), and signaling pathways (MAPK/ERK, PI3K/AKT, Rho-kinase), which act on both neurons and supporting glia, particularly Schwann cells[5][6][9][12]. Despite advances in surgical repair and regenerative medicine, peripheral nerve regeneration remains only partially effective, and therapeutic research targets enhancement through exogenous factor delivery, modulation of molecular pathways, and cell therapy approaches. There is no single therapeutic target or molecule called "peripheral nerve regeneration." Instead, interventions target key pathways, growth factors, or support cells involved in this process[9][12].

Other names
Peripheral nerve repairNerve regeneration (peripheral)
02

Mechanism of action

Activation of neurotrophic signaling pathways (e.g., MAPK/ERK, PI3K/AKT); Modulation of Schwann cell and macrophage activity to support nerve repair; Stimulation of axonal outgrowth, guidance, and remyelination by growth factors; Inhibition of inhibitory processes (e.g., Rho-kinase inhibition)

03

Biological functions

Axonal regrowthMyelinationDebris clearanceNeuronal survivalReinnervationSchwann cell proliferationImmune response
04

Disease associations

Neurodegenerative diseaseNerve injuryTraumaDiabetic neuropathyInflammation
05

Safety considerations

Short in vivo half-life and poor delivery of many growth factorsScar formation, neuroma, or inappropriate reinnervationTumorigenic potential of some growth factors (e.g., TGF-β)Immune modulation and possible off-target effects
06

Interacting drugs

Exogenous growth factors (e.g., nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factor (GDNF), insulin-like growth factor 1 (IGF-1), fibroblast growth factor (FGF))

3 more in the full profile.

07

Biomarkers

S100B protein (Schwann cell marker)Gap-43 (Growth Associated Protein 43)Evidence of expression of neurotrophic factors (e.g., NGF, BDNF)

Beyond the preview

Go deeper on Peripheral nerve regeneration.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peripheral nerve regeneration.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call